A recent study in Italy found that switching between biosimilars when treating patients in oncohematology centres for non-Hodgkin lymphoma or chronic lymphocytic leukaemia does not increase the risk ...
Cancer patients in the north of England are benefitting from a new nuclear medicine and molecular radiotherapy suite that is streamlining and personalising their care. Professor Jon Wadsley discusses ...
Personalised treatment innovations in the field of rheumatology are transforming patient care and outcomes, driven by significant advances in understanding the origins of rheumatological diseases.
Professor Antonio Almeida has been at the forefront of clinical haematology for more than 20 years and last year he became president of the European Hematology Association (EHA). Speaking to Julie ...
In September, the Royal College of Paediatrics and Child Health published its updated position statement on air pollution in the UK. Dr Emily Parker, RCPCH Clinical Fellow and one of the position ...
Genetics partly influence the shape of the heart’s left and right ventricles, a study shows for the first time, with the findings potentially helping to refine cardiovascular disease (CVD) risk ...